Cullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference

Rhea-AI Summary

Cullinan Oncology (Nasdaq: CGEM) announced its participation in the 4th Annual Evercore ISI HealthconX Conference from November 30 to December 2, 2021. CEO Nadim Ahmed will host a virtual fireside chat on December 1 at 2:15 PM ET. The management team will also engage in one-on-one investor meetings throughout the event, with interested investors encouraged to contact their Evercore representatives. Cullinan Oncology specializes in developing targeted oncology therapies aimed at addressing critical health challenges.

CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology therapies, today announced that it will be participating in the 4^th Annual Evercore ISI HealthconX Conference from November 30^th to December 2^nd, 2021.

Nadim Ahmed, Cullinan’s Chief Executive Officer, will participate in a virtual fireside chat on Wednesday December 1^st, 2021 at 2:15pm ET.

Management will also be participating in one-on-one investor meetings throughout the conference. Investors interested in scheduling a meeting with Cullinan’s management should contact their Evercore representative.

About Cullinan Oncology

Cullinan Oncology is a biopharmaceutical company with a diversified pipeline of targeted therapeutic candidates across multiple modalities. The Company’s strategy is to focus on advanced stage assets with novel technology platforms and differentiated mechanisms, developed through both internal discovery and external collaboration. Learn more about Cullinan at www.cullinanoncology.com.

Contacts:

Investor Relations
investors@cullinanoncology.com

Jeffrey Trigilio
+1 617.410.4650
jtrigilio@cullinanoncology.com

FAQ

When is Cullinan Oncology participating in the Evercore ISI HealthconX Conference?

Cullinan Oncology will participate in the 4th Annual Evercore ISI HealthconX Conference from November 30 to December 2, 2021.

What time is Nadim Ahmed's fireside chat at the Evercore ISI HealthconX Conference?

Nadim Ahmed's fireside chat is scheduled for December 1, 2021, at 2:15 PM ET.

How can investors schedule meetings with Cullinan Oncology's management during the conference?

Investors can schedule meetings with Cullinan Oncology's management by contacting their Evercore representative.

What does Cullinan Oncology focus on in its operations?

Cullinan Oncology focuses on developing a diversified pipeline of targeted oncology therapies with innovative technologies and differentiated mechanisms.

What is the stock symbol for Cullinan Oncology?

The stock symbol for Cullinan Oncology is CGEM.